Maternal hypothyroidism and adverse outcomes of pregnancy
Clinical Endocrinology · 2023-05 · 98 (5) · 719-729
DOI: 10.1111/cen.14853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 28.11.2022. Verfasst von Louise Knøsgaard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Premature Birth, Hypothyroidism, Pregnancy Complications. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Objective
Hypothyroidism has been associated with pregnancy complications, but uncertainty prevail regarding the severity and the role of thyroid autoimmunity. This study aimed to evaluate adverse pregnancy outcomes by exposure to maternal hypothyroidism and thyroid autoimmunity.
Design
Retrospective cohort study. Patients 14,744 singleton pregnancies from the North Denmark Region Pregnancy Cohort (2011−2015).
Measurements
Maternal thyroid stimulating hormone (TSH), thyroid peroxidase antibodies (TPO‐Ab), and thyroglobulin antibodies (Tg‐Ab) were retrospectively measured in early pregnancy blood samples (ADVIA Centaur XPT, Siemens Healthineers). Adjusted odds ratio (aOR) with 95% confidence interval (CI) was used to estimate associations between maternal hypothyroidism (TSH cut‐offs: 6.0 and 10 mIU/L), thyroid autoimmunity (TPO‐Ab cut‐off: 60 U/ml, Tg‐Ab cut‐off: 33 U/ml), and adverse pregnancy outcomes.
Results
Pregnancy outcomes were 93.2% live births, 6.5% spontaneous abortions, and 0.3% stillbirths. The frequency of spontaneous abortion was 6.5% when TSH was below 6.0 mIU/L, 6.5% when above 6.0 mIU/L (aOR 1.0 [95% CI: 0.5−2.0]), and 12.5% when above 10 mIU/L (aOR: 2.0 [95% CI: 0.8−5.2]). For outcome of preterm birth, the frequency was 5.4% when TSH was below 6.0 mIU/L, 7.8% when above 6.0 mIU/L (aOR 1.5 [95% CI: 0.7−2.9]), and 11.4% when above 10 mIU/L (aOR: 2.6 [95% CI: 0.9–7.3]). No association was found between thyroid autoantibodies and spontaneous abortion (TPO‐Ab: aOR: 1.0 [0.8−1.3], Tg‐Ab: 1.0 [0.8−1.2]) or preterm birth (TPO‐Ab: aOR: 1.0 [0.8–1.2], Tg‐Ab: 0.9 [0.7–1.2]).
Conclusion
A high frequency of adverse pregnancy outcomes was seen among pregnancies exposed to maternal TSH above 10 mIU/L, whereas no association with thyroid autoantibodies was seen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark.
- Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
- Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark.
ORCID-Profile: Louise Knøsgaard, Stine Linding Andersen
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Knøsgaard, L., Andersen, S., Hansen, A. B., Vestergaard, P., & Andersen, S. L. (2023). Maternal hypothyroidism and adverse outcomes of pregnancy. Clinical Endocrinology, 98(5), 719-729. https://doi.org/10.1111/cen.14853
Vancouver
Knøsgaard L, Andersen S, Hansen AB, Vestergaard P, Andersen SL. Maternal hypothyroidism and adverse outcomes of pregnancy. Clinical Endocrinology. 2023;98(5):719-729. doi:10.1111/cen.14853
BibTeX
@article{Knsgaard2023,
author = {Knøsgaard, Louise and Andersen, Stig and Hansen, Annebirthe Bo and Vestergaard, Peter and Andersen, Stine Linding},
title = {Maternal hypothyroidism and adverse outcomes of pregnancy},
journal = {Clinical Endocrinology},
year = {2023},
volume = {98},
number = {5},
pages = {719--729},
doi = {10.1111/cen.14853}
}
EUVIMED